Vanda Pharmaceuticals Inc

VNDA 
(NASDAQ) 
 
$ 13.44 <%= Resources.Global.txtDown %>
Updated 15/07/2019
Change % -0.96% Stock price decreasing
Change -0.13 Stock price decreasing
Volume 247,696
High $ 13.66
Low $ 13.38
Open $ 13.52
ISIN
Prev close $ 13.57
# of shares 52.96M
Market cap 711.83M USD
Intraday

Market closed
Vanda Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  13.44 -3.7% Stock price decreasing -9.8% Stock price decreasing -19.2% Stock price decreasing -56.4% Stock price decreasing -31.9% Stock price decreasing
Powered by TradingView

News about Vanda Pharmaceuticals Inc

  • English
  • Regulatory news
16 Jul
 
25 Apr
 
25 Apr
 
24 Apr
 
23 Apr
 
22 Apr
 
18 Apr
 
18 Apr
 
18 Apr
 
17 Apr
 

Company profile

Vanda Pharmaceuticals Inc is a biopharmaceutical company which is engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant (VLY-686), VTR-297, and VQW-765.

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
17 July 2019 06:20:43
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB5 - 2019-07-17 07:20:43 - 2019-07-17 06:20:43 - 1000 - Website: OKAY